Monopar Therapeutics Inc. Common Stock (MNPR) is a publicly traded Healthcare sector company. As of September 11, 2026, MNPR trades at $110.87 with a market cap of $754.31M and a P/E ratio of -60.29. MNPR moved +0.82% today. Year to date, MNPR is +66.58%; over the trailing twelve months it is +156.32%. Its 52-week range spans $26.06 to $124.82. Analyst consensus is strong buy with an average price target of $121.13. Rallies surfaces MNPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks MNPR insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $110.87 |
| Market Cap | $754.31M |
| P/E Ratio | -60.29 |
| EPS | $-1.85 |
| Dividend Yield | 0.00% |
| 52-Week High | $124.82 |
| 52-Week Low | $26.06 |
| Volume | 44 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.72M |
| Gross Margin | 0.00% |
8 analysts cover MNPR: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $121.13.